Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-14
2011-11-08
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S407000, C548S365400
Reexamination Certificate
active
08053458
ABSTRACT:
The present invention is directed to dipyrazole compounds of formula I and their pharmaceutically acceptable salts, stereoisomers, tautomers, or solvates thereof. Novel compounds include those of formula I.The compounds of this invention modulate AMPA and NMDA receptor function, and therefore are useful as pharmaceutical agents, especially for the treatment of neuropsychiatric disorders.
REFERENCES:
patent: 0976744 (2000-02-01), None
patent: WO 2005/040110 (2005-05-01), None
Kumar et al. “The structure of compounds . . . ” CA 123:255894 (1995).
Rachedi et al. “reaction of 4-hydroxyl . . . ” Ca 115:114412 (1991).
Borrell et al. “Design and synthesis of two pyrazole . . . ” Molecular diversity v.8, p. 147-157 (2004).
Bendaas et al. “Synthesis of bipyrazoles . . . ” CASREACT 132:166166 (1999).
Xie et al. “Synthesis and crystal . . . ” J. Hetercyclic Chem. v.45, p. 1485-1488 (2008).
DEas et al. “Heterocyclic fungicides” CA90:121480 (1979).
Obara et al. “Bipyrazole . . . ” CA133:232875 (2000).
Ohara et al. “Preparation of bipyrazole . . . ” CA130:38378(1998).
Federal Registry p. 1-34, Sep. 1, 2010.
Cantos, A., et. al., Synthesis of Pyrano{4,3-c}Pyrazol-4(1H)-Ones and -4(2H)-ones from Dehydroacetic Acid. Homo- and Heteronuclear Selective NOE Measurements for Unambiguous Structure Assignment, Bull. Chem. Soc. Jpn. vol. 60, p. 4425-4431 (1987).
Crippa, G.B., et. al., Ricerche Sul Chimismo Del Nucleo Pirazolico Trasposizione Da Bis-4-5′- in Bis-4-4′Pirazolene, Gazz. Chem. Ital. vol. 71, (1941), pp. 574-580.
Singh, S. P., et. al., A 1H and 13 C NMR Study of the Structure and Tautomerism of 4-Pyrazolylpyrazolinones, Journal of Heterocyclic Chemistry, vol. 27, (1990), pp. 865-870.
Singh, S. P., et. al., C-C Bond Cleavage Studies in Bipyrazoles: A Convenient Synthesis of Pyrazolo-5-ols, Synthetic Communications, vol. 35, pp. 611-619, (2005).
Singh, S. P., et. al., Reaction of 1-[5-Hydroxy-3-Methy1-1-(2-Thiazoly1)-4-Pyrazolyl]- 1,3-Butanediones With Phenyl and Heterocyclic Hydrazines: A Convenient Synthesis of 4,5′ -Bipyrazoles, Indian Journal of Heterocyclic Chemistry vol. 3, (1993), pp. 5-8.
Singh, S.P., et. al., Mass Spectra of Some 3, 3′-Dimethyl (4,5-Bipyrazol)-5-Ols, Organic Mass Spectrometry, vol. 20, No. 7, (1985) pp. 484-485.
Interchim Intermediates, Database Chemcats (2005) Order No. 10E-969, 10E-914, 10E-973, 10E-944, 10E-974, 10E-921, 10E-937, 7E-913, and RN 303997-19-5, abstract.
Kosley Raymond W.
MacDonald Douglas
Sher Rosy
Aventis Pharmaceuticals Inc.
Bell Craig M.
Bender Kelly L.
Chang Celia
LandOfFree
Dipyrazole compounds and their use as central nervous system... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dipyrazole compounds and their use as central nervous system..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipyrazole compounds and their use as central nervous system... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4304481